NOW Glycine 1000mg vegetarian capsules โ€” glycine supplement available in Ireland from Probiotic.ie

Glycine Supplement Ireland: Sleep, Collagen & Evidence Guide

Evidence Guide ยท Glycine Supplement Ireland ยท April 2026

Glycine is the smallest amino acid in the human body โ€” and one of the most studied supplements for sleep quality. This guide covers what the human clinical trials actually show, how glycine works, and what Irish adults should know before supplementing.

Quick Answer

Glycine is a non-essential amino acid found naturally in collagen and protein-rich foods. As a supplement, its best-evidenced use is sleep quality support โ€” human trials using 3 g before bedtime have shown reductions in sleep onset latency and slow wave sleep latency in polysomnographic measurements.

The dose in published sleep trials (3 g) matches exactly the serving size of NOW Glycine 1000mg (3 capsules = 3,000 mg). Secondary areas of interest include its role as a collagen building block and as part of the GlyNAC stack (glycine + N-acetylcysteine) studied in the context of glutathione deficiency and ageing.

Glycine is not the same as magnesium glycinate. Magnesium glycinate is a magnesium supplement; glycine is the carrier, not the active compound.

Evidence Summary

What is well-supported: Three human studies (Inagawa et al. 2006, Yamadera et al. 2007, Bannai et al. 2012) consistently associate 3 g glycine before bedtime with improved subjective sleep quality and, in polysomnographic measurement, shorter latency to sleep onset and slow wave sleep.

What is not proven: Direct collagen synthesis benefits from isolated glycine supplementation in healthy adults have not been established in controlled human RCTs; the GlyNAC longevity data is promising but based on small pilot trials and a 2023 RCT in older adults, not in the general adult population.

Most relevant human dose range: 3 g (3,000 mg) before bedtime for sleep; 1.8โ€“3.8 g glycine component in GlyNAC trials (varies by study).

Key safety note: No serious adverse events were observed at 9 g in human safety studies. Consult a GP before use if taking antipsychotic medication โ€” glycine at high doses has been studied as an adjunct in schizophrenia treatment, where drug interactions are relevant.

Feature Detail Evidence Level
Compound type Non-essential amino acid (endogenously synthesised) Established
Primary dietary source Collagen-rich foods โ€” bone broth, meat, fish, gelatin Established
Sleep quality (subjective) 3 g before bed improved sleep quality in 3 human trials Human RCT
Sleep onset latency Shortened in PSG study โ€” Yamadera et al. (p = 0.01) Human RCT
Slow wave sleep latency Shortened in PSG study โ€” Yamadera et al. (p = 0.019) Human RCT
Proposed sleep mechanism NMDA receptor modulation in suprachiasmatic nucleus โ†’ core body temperature reduction Preclinical + mechanistic
Collagen synthesis role Structural requirement (every 3rd residue in collagen triple helix) Established biology
Isolated glycine โ†’ collagen synthesis in humans Not established in human RCTs Not proven
GlyNAC โ†’ glutathione in older adults Improved in Sekhar et al. RCT (2023, Baylor College of Medicine) Small RCT
Safe dose ceiling (human data) 9 g assessed โ€” no serious adverse events (Inagawa et al. 2006) Human safety study
Amino Acid Basics

What Is Glycine?

Glycine (2-aminoacetic acid) is the smallest of the 20 standard amino acids. Its molecular simplicity โ€” a single hydrogen atom in place of a side chain โ€” makes it structurally unique and biologically versatile. It is classified as a non-essential amino acid, meaning the human body synthesises it endogenously, primarily in the liver and kidneys from serine, threonine, and other precursors. Adult endogenous synthesis is estimated at approximately 3 g per day.1

Dietary glycine comes principally from collagen-rich foods โ€” bone broth, meat (particularly cuts containing connective tissue), pork skin, fish, and gelatin. A typical Western diet provides an estimated 1.5โ€“3 g per day from food, meaning total daily availability from synthesis plus diet is roughly 4โ€“6 g. Whether this is sufficient under conditions of high physiological demand โ€” such as in older adults, periods of high physical stress, or where collagen turnover is elevated โ€” is an active area of research.

Glycine has multiple biological roles. It is a structural component of collagen (the most abundant protein in the body), a precursor for glutathione synthesis, a building block of creatine and bile salts, and a neurotransmitter. In the central nervous system, glycine functions as an inhibitory neurotransmitter via strychnine-sensitive glycine receptors and as a co-agonist at excitatory NMDA (N-methyl-D-aspartate) receptors โ€” a dual role that makes it relevant to both sleep and cognition research.

~33%
of collagen's amino acid composition is glycine
3 g
dose used in published human sleep trials
p=0.01
sleep onset latency result, Yamadera et al. 2007
9 g
highest dose assessed in human safety study โ€” no serious AEs
Primary Evidence

Glycine for Sleep โ€” What the Evidence Shows

Sleep quality is the most consistently supported application of glycine supplementation in human trials. Three studies form the core of this evidence base, all using 3 g of glycine taken before bedtime.

The earliest systematic data came from Inagawa et al. (Sleep and Biological Rhythms, 2006), a randomised double-blinded crossover trial in volunteers reporting chronic sleep dissatisfaction. Subjective sleep quality improved significantly compared to placebo.2 Yamadera et al. (Sleep and Biological Rhythms, 2007) then extended this with polysomnographic (PSG) measurement โ€” objective brain wave monitoring during sleep โ€” in participants with an average Pittsburgh Sleep Quality Index score of 8.07, indicating clinically meaningful sleep dissatisfaction. PSG showed significant shortening of latency to sleep onset (p = 0.01) and latency to slow wave sleep (p = 0.019), without alteration of overall sleep architecture.3 Slow wave sleep โ€” also called deep sleep or Stage 3 NREM sleep โ€” is the most physically restorative sleep stage. Shortening the time to reach it is meaningfully different from simply increasing sedation.

Bannai et al. (Frontiers in Neurology, 2012, Ajinomoto Co., Kanagawa, Japan) took a different angle, assessing daytime consequences of restricted sleep in healthy adults. Volunteers had sleep restricted to 75% of their normal duration for three consecutive nights. Those who received 3 g glycine before bed reported significantly reduced daytime sleepiness and fatigue compared to placebo on the visual analogue scale and a structured questionnaire.4 This matters practically: poor sleep's real-world impact is often felt the following day, not just at night.

RCT โ€” Crossover
Yamadera et al. (2007) โ€” Polysomnographic confirmation of sleep onset and slow wave sleep shortening

Yamadera W, Inagawa K, Chiba S, Bannai M, Takahashi M, Nakayama K conducted a randomised, double-blind, crossover trial in volunteers with continuous sleep dissatisfaction (mean PSQI 8.07). Participants received 3 g glycine or placebo before bedtime. PSG measurements showed significant shortening of latency to sleep onset (p = 0.01) and latency to slow wave sleep (p = 0.019). Sleep architecture โ€” the ratio of each sleep stage across the night โ€” was not altered. Daytime sleepiness improved and memory recognition task performance was associated with improvement in the glycine group.

Yamadera W et al. Sleep Biol Rhythms. 2007;5:126โ€“131. DOI: 10.1111/j.1479-8425.2007.00262.x

RCT โ€” Crossover
Bannai et al. (2012) โ€” Reduced daytime sleepiness and fatigue following glycine in sleep-restricted adults

Bannai M, Kawai N, Ono K, Nakahara K, Murakami N (Frontier Research Labs, Ajinomoto Co., Japan) evaluated 3 g glycine vs placebo before bed over three nights of 25%-restricted sleep in healthy volunteers with normal baseline PSQI scores. The glycine group showed significantly reduced daytime sleepiness and fatigue on the visual analogue scale (VAS) and structured questionnaire. Psychomotor vigilance test reaction time also improved in the glycine group. This trial is notable for testing glycine in people without pre-existing sleep complaints โ€” suggesting potential relevance beyond those with chronic sleep dissatisfaction.

Bannai M et al. Front Neurol. 2012;3:61. DOI: 10.3389/fneur.2012.00061

Systematic Review โ€” Mixed
2024 Systematic Review (PMC10828290) โ€” Promising signal, limited evidence in healthy populations

A 2024 systematic review (PROSPERO CRD42022312730, conducted at National University of Singapore) searched Embase, PubMed, Web of Science, and Cochrane CENTRAL and included all human adult study designs. The review found that glycine administration may improve characteristics across multiple physiological systems. However, the authors concluded that evidence is limited for preventative effects in healthy populations, and a meta-analysis could not be performed due to high heterogeneity across studies. This is an important caveat โ€” the sleep trials were conducted in people with sleep dissatisfaction or restricted sleep, not in universally healthy sleepers.

Systematic Review. PMC10828290. 2024. Available: pmc.ncbi.nlm.nih.gov/articles/PMC10828290/

Safety Study
Inagawa et al. (2006) โ€” 9 g glycine assessed in human volunteers, no serious adverse events

Inagawa K, Kawai N, Ono K, Sukegawa E, Tsubuku S, Takahashi M assessed 9 g of glycine โ€” three times the standard 3 g sleep dose โ€” in a randomised single-blind crossover trial of 11 volunteers. Clinical parameters including blood amino acid levels showed changes that were within the range of physiological normal variation. Minor digestive symptoms were noted after bedtime ingestion but were not considered serious. Importantly, no daytime sleepiness carry-over effect was observed, addressing a practical concern for working adults. This provides a reasonable safety margin above the 3 g dose used in sleep trials.

Inagawa K et al. J Urban Living Health Assoc. 2006;50(1):27โ€“32.

Important Limitation

The sleep trials by Yamadera et al. and Bannai et al. were conducted by researchers affiliated with Ajinomoto Co., Inc. โ€” a major glycine manufacturer. This does not invalidate the findings, but it is a relevant conflict of interest to note. Independent replication in larger, longer trials by non-industry groups would strengthen the evidence base. The polysomnographic data from Yamadera et al. is objective and peer-reviewed, which reduces (but does not eliminate) this concern.

Mechanism of Action

How Glycine Is Thought to Support Sleep

The most coherent proposed mechanism for glycine's effect on sleep involves core body temperature regulation. Core body temperature naturally drops in the hours before and during sleep onset โ€” this drop is a known physiological prerequisite for initiating sleep. Kawai et al. (Neuropsychopharmacology, 2015, Ajinomoto Co. and Stanford University Sleep and Circadian Neurobiology Laboratory, led by Seiji Nishino) showed that oral glycine acts on NMDA receptors in the suprachiasmatic nucleus (SCN) โ€” the brain's primary circadian clock โ€” leading to peripheral vasodilation and a reduction in core body temperature.5

The suprachiasmatic nucleus location is significant. The SCN governs circadian rhythm, body temperature cycling, and the timing of melatonin release. Glycine's proposed action is not sedation in the way a benzodiazepine or antihistamine sedates โ€” it does not suppress the nervous system broadly. The mechanism, if confirmed, is more analogous to supporting the physiological conditions that the body uses to initiate sleep naturally. This is consistent with the observation in Yamadera et al. that sleep architecture (the ratio of sleep stages) was not altered โ€” only the time to reach each stage was shortened.

Glycine also functions as an inhibitory neurotransmitter via strychnine-sensitive glycine receptors in the brainstem and spinal cord, and as a co-agonist at NMDA receptors throughout the CNS. Its capacity to passively cross the blood-brain barrier (confirmed in rat models by Kawai et al.) means oral supplementation can influence CNS activity directly.5

๐ŸŒก๏ธ
Core Temperature Reduction

Glycine is proposed to act on NMDA receptors in the suprachiasmatic nucleus, triggering peripheral vasodilation and a reduction in core body temperature โ€” a prerequisite for sleep onset.

๐Ÿง 
Inhibitory Neurotransmission

Glycine acts as an inhibitory neurotransmitter in the brainstem and spinal cord via glycine receptors, contributing to a general reduction in motor neuron excitability during sleep.

๐Ÿ”„
NMDA Receptor Co-Agonism

At NMDA glutamate receptors throughout the CNS, glycine acts as a co-agonist. This dual excitatory/inhibitory role is thought to influence both sleep regulation and cognitive function.

โฑ๏ธ
Circadian Rhythm Interaction

The suprachiasmatic nucleus is the master circadian clock. Glycine's proposed action on SCN NMDA receptors may help align core temperature cycling with sleep timing.

๐Ÿฉธ
Blood-Brain Barrier Crossing

Ingested glycine passively diffuses across the blood-brain barrier by non-specific transportation โ€” confirmed in rat models by Kawai et al. (2012). This supports the plausibility of oral supplementation affecting CNS function.

๐Ÿ’ค
Slow Wave Sleep Acceleration

In PSG measurement (Yamadera et al. 2007), glycine shortened latency to slow wave sleep (Stage 3 NREM) โ€” the most physically restorative sleep stage โ€” without disrupting overall sleep architecture.

Frequently Confused

Glycine vs Magnesium Glycinate โ€” Key Differences

This is the most common source of confusion in the glycine supplement category, and it matters for product selection. The two are chemically and functionally different.

Glycine (this product) is a standalone amino acid supplement. The active compound is glycine itself. It is used for its own biological roles โ€” including the sleep quality effects described above and its function in glutathione and collagen synthesis. NOW Glycine 1000mg delivers 3,000 mg of free-form glycine per serving with no additional minerals.

Magnesium glycinate is a chelated mineral supplement. Glycine here is the chelating agent โ€” it binds to magnesium ions to form a stable, well-absorbed compound. The active compound of interest is magnesium. The glycine content in a magnesium glycinate capsule contributes a relatively small amount of free glycine and is not the primary reason for taking it. Someone choosing magnesium glycinate is primarily supplementing magnesium; someone choosing a glycine supplement is supplementing the amino acid itself.

The published sleep quality trials (Yamadera et al. 2007, Bannai et al. 2012) used isolated glycine โ€” not magnesium glycinate. The sleep effects observed in those trials cannot be attributed to magnesium glycinate and vice versa. Both compounds have independently relevant research contexts, but they should not be conflated.

Feature Glycine (Free-Form) Magnesium Glycinate
Primary active compound Glycine (amino acid) Magnesium (mineral)
Role of glycine in compound The active ingredient Chelating carrier only
Sleep quality RCT evidence Yes โ€” Yamadera 2007, Bannai 2012 Separate magnesium evidence base
Proposed sleep mechanism NMDA/SCN โ€” core temp reduction Magnesium โ€” GABA modulation
Relevant for glutathione synthesis (GlyNAC) Yes No โ€” glycine dose in Mg glycinate is insufficient
Relevant for collagen amino acid supply Yes (at 3 g serving) Minor, secondary
Magnesium supplementation No Yes โ€” primary benefit
Related Guide

For a full comparison of magnesium forms including glycinate, bisglycinate, and citrate โ€” including EFSA-referenced dosage and the sleep-specific evidence for magnesium โ€” see our Magnesium for Sleep Ireland guide. Glycine and magnesium glycinate serve different purposes and the choice between them depends on what you are primarily addressing.

Structural Role

Glycine and Collagen Synthesis

Glycine is the most abundant amino acid in collagen, accounting for approximately one-third of total amino acid composition. The reason is structural: collagen has a characteristic repeating tripeptide sequence (Gly-X-Y), where every third position must be occupied by glycine. Glycine is the only amino acid small enough to fit inside the tightly wound collagen triple helix โ€” larger amino acids at this position prevent the helix from forming correctly.

This means glycine is a required structural input for collagen synthesis. When cells synthesise new collagen, glycine must be available. Whether the availability of supplemental glycine increases collagen production in healthy adults โ€” beyond what endogenous synthesis and diet already supply โ€” is a different question, and one that current human RCT evidence does not clearly answer for isolated glycine supplementation.

The most relevant human collagen-amino acid research has used gelatin or collagen peptide formulations (which deliver glycine alongside proline and hydroxyproline) rather than isolated glycine. Shaw et al. (2017) showed that vitamin C-enriched gelatin increased circulating glycine, proline, and hydroxyproline, and was associated with increased markers of collagen synthesis in an exercise context. A 2025 clinical observational trial published in npj Aging (Colgevity formulation, ETH Zurich collaboration) used a 3:1:1 ratio of glycine, proline, and hydroxyproline and found improved skin features and a reduction in biological age of 1.4 years (p = 0.04) over six months โ€” but this was a combined formulation, not isolated glycine.6

The practical implication: glycine supplementation is consistent with supporting collagen substrate availability, but should not be marketed or interpreted as a proven collagen synthesis enhancer on isolated glycine data alone.

Longevity Stack

GlyNAC โ€” The Glycine and NAC Stack

GlyNAC is a combination of glycine and N-acetylcysteine (NAC) that has attracted significant attention in longevity and healthy ageing research. The logic is biochemical: glutathione โ€” the body's most abundant intracellular antioxidant โ€” is a tripeptide composed of glycine, cysteine, and glutamate. Glutamate is rarely limiting. In older adults, both glycine and cysteine availability decline, impairing glutathione synthesis and elevating oxidative stress.

Dr. Rajagopal Sekhar and colleagues at Baylor College of Medicine, Houston, Texas, have conducted the most substantial human GlyNAC research. A 2023 randomised clinical trial in older adults showed that 24 weeks of GlyNAC supplementation improved glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and physical function compared to placebo.7 A 2021 pilot trial from the same group showed improvements across multiple recognised hallmarks of ageing.

It is important to be precise about what this means: the 2023 RCT was in older adults with documented deficiencies, not in the general healthy adult population. GlyNAC is a combination; glycine alone does not deliver the GlyNAC effect. Probiotic.ie stocks NAC supplements separately โ€” both glycine and NAC would be required to replicate the GlyNAC protocol, and the specific doses in the Sekhar trials should be reviewed before attempting to self-administer.

Research Context โ€” Not Product Claims

The GlyNAC research discussed in this section relates to glycine as a studied compound in the context of glutathione synthesis and ageing biology. It should not be read as a claim that NOW Glycine 1000mg produces these effects. This product is a food supplement, not a medicine. No authorised EU health claim is currently made for glycine on this page or on the product under EC Regulation 1924/2006.

Practical Guidance

Dosage Guide for Ireland

The dose used consistently across published sleep trials is 3 g (3,000 mg), taken shortly before bedtime. This corresponds to 3 capsules of NOW Glycine 1000mg taken as a single evening serving. The label also allows for a flexible 1โ€“3 capsule daily dose taken on an empty stomach, which can be adjusted depending on individual response.

There is no published human RCT comparing 1 g, 2 g, and 3 g doses for sleep outcomes โ€” so it is not possible to say whether a lower dose produces equivalent benefit. The 3 g dose is what the evidence supports. Exceeding the label dose is not recommended without GP guidance. In human safety studies (Inagawa et al. 2006), 9 g was assessed without serious adverse events, but this should not be interpreted as a licence to take three times the recommended dose.

What to expect โ€” a realistic timeline

Night 1โ€“3
Some users notice feeling more settled before sleep. In the Bannai et al. (2012) trial, effects on daytime sleepiness were measurable after three nights of restricted sleep. Individual response will vary.
Week 1โ€“2
The Yamadera et al. (2007) polysomnographic trial was conducted over multiple nights. Consistent use before bed gives the best basis for assessing whether glycine is working for you. Note any changes in how quickly you fall asleep or how rested you feel on waking.
Week 4+
If sleep quality has not noticeably changed by week 4 of consistent nightly use, glycine may not be the right approach for your specific sleep difficulty. Chronic sleep problems should be assessed by a GP โ€” glycine is not a substitute for professional advice.
Ongoing
Glycine is not known to be habit-forming. Available human studies have not identified tolerance, dependency, or rebound insomnia on cessation โ€” though long-term controlled data remains limited. The safety study (Inagawa et al. 2006) found no serious adverse events at 9 g. Glycine is not a sedative in the pharmacological sense.
When to See a GP

If you experience persistent difficulty sleeping for more than three to four weeks, or if your sleep is consistently disrupted by anxiety, pain, restless legs, or breathing irregularities, consult your GP. These may indicate conditions requiring assessment and treatment. Glycine supplementation is not an appropriate substitute for medical evaluation of chronic insomnia or sleep disorders. FSAI-regulated food supplements cannot diagnose, treat, or prevent medical conditions.

Product Guide

Where to Buy Glycine Supplement in Ireland

NOW Glycine 1000mg โ€” 100 Free-Form Vegetarian Capsules is available directly from Probiotic.ie with nationwide Ireland delivery. It is manufactured by NOW Foods (family-owned since 1968, USA) under GMP Quality Assured conditions and delivers pharmaceutical-grade, free-form glycine โ€” meaning the glycine is in its pure, unbound state for direct absorption without requiring enzymatic digestion of peptide bonds.

Who Glycine May Suit

May suit: adults looking for a standalone amino acid supplement rather than a mineral supplement, those comparing free-form glycine with magnesium glycinate for sleep, and people interested in the 3 g glycine dose used in published human sleep studies.

May not suit: pregnant or breastfeeding women, children under 18, people taking prescription medication without prior GP advice, or anyone experiencing persistent sleep difficulties that have not been assessed by a doctor. Glycine is not a substitute for medical evaluation of chronic insomnia.

Product Details Verified

Product details on this page โ€” including dose (1,000 mg per capsule, 3,000 mg per serving of 3 capsules), capsule count (100 caps = approximately 33 servings), grade (pharmaceutical-grade, free-form), capsule type (hypromellose โ€” vegan), and price (โ‚ฌ24.95) โ€” were verified by Probiotic.ie from current NOW Foods packaging and supplier information. Product details should always be checked against the current label before use, as formulations and pricing may change.

Research Context โ€” Not Product Claims

The clinical sleep research discussed in this article relates to glycine as a studied compound. It should not be read as a claim that NOW Glycine 1000mg produces these effects. This product is a food supplement regulated under FSAI guidelines, not a medicine. No authorised EU health claim is currently made for glycine sleep effects on this page or on the product under EC Regulation 1924/2006.

NOW Glycine 1000mg โ€” 100 Free-Form Veg Capsules

Free-form glycine providing 1,000 mg per capsule and 3,000 mg per 3-capsule serving. The 3 g serving matches the glycine dose used in the published human sleep studies by Yamadera et al. and Bannai et al.

1,000 mg per capsule 3,000 mg per serving Pharmaceutical Grade Vegan Capsule GMP Quality Assured 100 Capsules
View Product โ€” โ‚ฌ24.95

Authorised Irish retailer for NOW Foods ยท Nationwide Ireland delivery ยท Free delivery over โ‚ฌ75 ยท Not a medicine ยท Regulated under FSAI food supplement guidelines

Common Questions

Frequently Asked Questions

Does glycine help with sleep?

Human clinical data suggests glycine may support sleep quality when taken before bedtime. Yamadera et al. (Sleep and Biological Rhythms, 2007) found that 3 g of glycine shortened latency to sleep onset (p = 0.01) and to slow wave sleep (p = 0.019) in polysomnographic measurements. Bannai et al. (Frontiers in Neurology, 2012) found it reduced daytime sleepiness and fatigue in sleep-restricted adults. These are small trials conducted in people with sleep dissatisfaction or restricted sleep โ€” findings should not be extrapolated beyond these populations without further research.

How much glycine should I take for sleep?

The dose used in published human sleep trials is 3 g (3,000 mg), taken shortly before bedtime. This is 3 capsules of NOW Glycine 1000mg taken as a single serving. No human sleep trial has compared different doses, so it is not known whether lower amounts are equally effective. Do not exceed the label dose without consulting your GP.

What is glycine and what is it used for?

Glycine is the smallest and simplest amino acid, synthesised endogenously and obtained from collagen-rich foods. It has multiple biological roles: a structural component of collagen (one-third of all collagen amino acids), a precursor for glutathione and creatine synthesis, and a neurotransmitter in the CNS. As a supplement, the best-evidenced use is sleep quality support at 3 g before bed. It is also used as the glycine component of GlyNAC (with NAC) in the context of glutathione and healthy ageing research.

Is glycine the same as magnesium glycinate?

No. Glycine is a standalone amino acid supplement โ€” the active compound is glycine itself. Magnesium glycinate is a chelated magnesium supplement in which glycine acts as the carrier to improve magnesium absorption. Someone taking magnesium glycinate is primarily supplementing magnesium, not glycine. The sleep quality RCTs (Yamadera 2007, Bannai 2012) used isolated glycine โ€” not magnesium glycinate.

What is GlyNAC and how does glycine relate to it?

GlyNAC is a combination of glycine and N-acetylcysteine (NAC). Both are precursors for glutathione synthesis. Rajagopal Sekhar et al. at Baylor College of Medicine conducted a 2023 RCT showing GlyNAC improved glutathione deficiency, oxidative stress, and multiple hallmarks of ageing in older adults. Glycine alone is not equivalent to GlyNAC โ€” the NAC component (providing cysteine) is required to address both limiting precursors for glutathione synthesis.

What is the role of glycine in collagen?

Glycine makes up approximately one-third of collagen's amino acid composition. The collagen triple helix has a repeating Gly-X-Y structure โ€” every third position must be glycine, as it is the only amino acid small enough to occupy the interior of the helix. Glycine is therefore a structural requirement for collagen synthesis. Whether isolated glycine supplementation increases collagen production in healthy adults has not been established in human RCTs โ€” the most relevant collagen-amino acid trials have used gelatin or collagen peptide formulations.

Is glycine supplement safe?

Glycine has a well-characterised safety profile at supplemental doses. Inagawa et al. (2006) assessed 9 g in human volunteers โ€” three times the 3 g sleep dose โ€” and found no serious adverse events. Minor digestive symptoms were noted at the higher dose. Glycine is not known to be habit-forming and available human studies have not identified tolerance, dependency, or rebound insomnia on cessation, though long-term controlled data remains limited. Consult a GP before use if pregnant, breastfeeding, or taking prescription medication โ€” particularly antipsychotic drugs, as high-dose glycine has been studied as an adjunct treatment in schizophrenia.

What foods are high in glycine?

Glycine is found in highest concentrations in collagen-rich foods: bone broth, pork skin, chicken skin, gelatine, and connective tissue cuts of meat. It is also present in fish, dairy, and legumes at lower levels. The body synthesises approximately 3 g per day from serine and threonine; a typical Western diet provides an additional estimated 1.5โ€“3 g. Some researchers, including the Baylor GlyNAC team, have proposed that total availability may be insufficient in older adults or under high physiological demand.

How long does glycine take to work for sleep?

In Yamadera et al. (2007), PSG effects on sleep onset and slow wave sleep latency were measurable from the first night. Bannai et al. (2012) used a three-night protocol and showed daytime sleepiness improvements across that window. There is no evidence of a loading period. If there is no noticeable benefit after four weeks of consistent nightly use at 3 g, glycine may not be appropriate for your sleep difficulty, and a GP consultation is advisable.

Where can I buy glycine supplement in Ireland?

NOW Glycine 1000mg โ€” 100 Free-Form Vegetarian Capsules is available from Probiotic.ie, an Irish-owned supplement retailer regulated under FSAI food supplement guidelines, with nationwide Ireland delivery. The product is manufactured by NOW Foods under GMP Quality Assured conditions and provides 3,000 mg of pharmaceutical-grade, free-form glycine per 3-capsule serving โ€” the dose used in the published sleep trials.

Related Guides

DG
Darren Grant โ€” Managing Director, Probiotic.ie

Darren Grant is the Managing Director of TenX Tech Ltd, operating Probiotic.ie and Probiotic.co.uk. He has over five years of experience in food supplement retail and distribution in Ireland and the UK, with a focus on FSAI-compliant content and evidence-based product selection. All guides are written to FSAI food supplement guidelines under EC Regulation 1924/2006.

Disclaimer: This guide is for educational purposes only and does not constitute medical advice. NOW Glycine 1000mg is a food supplement regulated under FSAI guidelines and is not intended to diagnose, treat, cure, or prevent any disease or medical condition. If you have persistent or worsening sleep difficulties, consult a GP or relevant specialist. Probiotic.ie is regulated under FSAI food supplement guidelines.

Sources

  1. Systematic Review. The effect of glycine administration on the characteristics of physiological systems in human adults. PMC10828290. 2024 โ€” pmc.ncbi.nlm.nih.gov/articles/PMC10828290/
  2. Bannai M, Kawai N. New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep. J Pharmacol Sci. 2012;118(2):145โ€“148 โ€” pubmed.ncbi.nlm.nih.gov/22293292/
  3. Yamadera W, Inagawa K, Chiba S, Bannai M, Takahashi M, Nakayama K. Glycine ingestion improves subjective sleep quality in human volunteers, correlating with polysomnographic changes. Sleep Biol Rhythms. 2007;5:126โ€“131 โ€” doi.org/10.1111/j.1479-8425.2007.00262.x
  4. Bannai M, Kawai N, Ono K, Nakahara K, Murakami N. The effects of glycine on subjective daytime performance in partially sleep-restricted healthy volunteers. Front Neurol. 2012;3:61 โ€” pubmed.ncbi.nlm.nih.gov/22529837/
  5. Kawai N, Sakai N, Okuro M, Karakawa S, Tsuneyoshi Y, Kawasaki N, Takeda T, Bannai M, Nishino S. The sleep-promoting and hypothermic effects of glycine are mediated by NMDA receptors in the suprachiasmatic nucleus. Neuropsychopharmacology. 2015;40(6):1405โ€“1416 โ€” pubmed.ncbi.nlm.nih.gov/25533534/
  6. Collagen amino acid composition supplementation reduces biological age in humans and increases health and lifespan in vivo. npj Aging. 2025 โ€” pmc.ncbi.nlm.nih.gov/articles/PMC12635253/
  7. Kumar P, Sekhar R et al. Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial. J Gerontol A Biol Sci Med Sci. 2023 โ€” pmc.ncbi.nlm.nih.gov/articles/PMC9879756/